Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC [NA]
Phase I clinical trial evaluating vGRID SBRT for unresectable or metastatic hepatocellular carcinoma, currently recruiting at University of …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
This clinical trial update reports long-term survival outcomes for patients with unresectable hepatocellular carcinoma treated with a lenvat…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study. [Phase 1]
Phase 1 feasibility study assessing neoadjuvant hypofractionated stereotactic body radiotherapy before surgery for hepatocellular carcinoma;…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS) [NA]
A completed study evaluating real-time contrast-enhanced ultrasound for characterizing focal liver lesions, including liver cancer and cirrh…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1) [Phase 1]
A Phase I trial evaluating IMA970A plus Montanide in combination with durvalumab (anti-PD-L1) for hepatocellular carcinoma is currently acti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery [Phase 3]
This Phase 3 clinical trial update describes a study evaluating cisplatin-based chemotherapy after surgery for children and young adults wit…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease
A clinical trial registry entry from University Hospital Muenster outlining a study to predict decompensation and hepatocellular carcinoma d…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria [NA]
This entry reports a clinical trial (TITAN-HCC) evaluating QL1706 with transarterial chemoembolization (TACE) as neoadjuvant and adjuvant th…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions [NA]
Clinical trial update for contrast-enhanced MRI to detect benign and malignant liver lesions; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC [EARLY_Phase 1]
A Phase 1 clinical trial is investigating NIR-II fluorescence-guided hepatectomy using ICG-Cisplatin nanoprobes for hepatocellular carcinoma…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
A clinical trial update describing an ongoing study comparing MRI and ultrasound for detecting primary hepatocellular carcinoma and evaluati…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection
A clinical trial evaluating the diagnostic accuracy of folate-targeted NIR-II carbon dots for detecting hepatocellular carcinoma in ex vivo …
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC) [Phase 1]
Phase 1 clinical trial update evaluating perioperative nivolumab with or without relatlimab in patients with potentially resectable hepatoce…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation [NA]
This clinical trial compared biliary anastomosis using a surgical loupe versus a microscope in living donor liver transplantation. The study…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma [Phase 3]
Phase 3 trial evaluating ADI-PEG 20 versus placebo in patients with high arginine levels and unresectable hepatocellular carcinoma is curren…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma
A clinical trial update reports that immune cell biomarkers may predict responses to immunotherapy in advanced hepatocellular carcinoma; the…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC [Phase 1]
A Phase 1 study of MT-303 in adults with advanced or metastatic GPC3-expressing cancers, including hepatocellular carcinoma, is currently re…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention [Phase 1, Phase 2]
Update on a Phase 1/2 clinical trial evaluating a multimodal deep learning approach to risk stratification and intervention following hepato…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: JMT106 Injection in the Treatment of Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating JMT106 injection for advanced solid tumors, including lung squamous cell carcinoma and hepatocellular carcinoma, is…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy
This clinical trial update describes an ongoing study comparing surgical resection versus observation for patients with initially unresectab…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Predictors and Outcome of Rupture HCC in AU Hospitals
Assiut University is conducting a clinical trial to identify predictors and outcomes of ruptured hepatocellular carcinoma in Assiut Universi…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. [Phase 2, Phase 3]
A multi-center randomized Phase 2/3 trial evaluating neoadjuvant hepatic arterial infusion chemotherapy with transarterial chemoembolization…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD [Phase 2, Phase 3]
A phase 2/3 clinical trial is evaluating sequential bevacizumab and atezolizumab in advanced hepatocellular carcinoma associated with MASLD;…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
A clinical trial is evaluating glypican-3 as a prognostic factor in hepatocellular carcinoma patients treated with immunotherapy and is curr…